• Skip to main content

Diagnosis: Multiple Sclerosis

Coping with multiple sclerosis symptoms, attacks, and treatments

  • Home
  • About
  • Subscribe
  • What Is MS?
  • Gilenya
  • Contact Us

natalizumab

Are Neurologists Pushing Tysabri?

May 13, 2010 by Sara

Are Neurologists Pushing Tysabri?
Tysabri : A picture is worth $6900!

It was a dark and stormy night. The hospital corridors were abandoned and echoing with every step. There was a suspicious lack of signage directing individuals to the basement seminar. I had no idea that I had registered for an evening of neurologists pushing Tysabri onto a room full of medicare patients.

My parents assured me that although they’ve gone to many MS events they had never been to a spectacle like this before.

Last night I trekked down to the basement of a hospital branch one county away to attend an MS event my parents had alerted me to called Dialogue of Hope and Health. I can’t deny that I was hoping that the “hope” in the title of the event referred to the new oral medications soon to be available (at least in other countries) or perhaps stem cell developments. It turned out to be something between a sales pitch and damage control conducted by a local neurologist and some Tysabri sales reps.

[Read more…] about Are Neurologists Pushing Tysabri?

Filed Under: clabridine, copaxone, fingolimod, gilenya, insurance, liver damage, multiple sclerosis, rebif, research, treatment, tysabri Tagged With: cladribine, copaxone, disease, fingolimod, gilenya, injection, interferon, ms, ms attack, multiple sclerosis, natalizumab, neurological disorder, neurologist, pill, pml, rebif, tysabri

Copyright © 2022 · Infinity Pro on Genesis Framework · WordPress · Log in

 

Loading Comments...